Section of Pulmonary/Critical Care, Department of Medicine, University of Chicago, Chicago, IL.
Section of Pulmonary/Critical Care, Department of Medicine, University of North Carolina, Chapel Hill, NC.
Chest. 2018 Oct;154(4):773-780. doi: 10.1016/j.chest.2018.04.018. Epub 2018 Apr 24.
Lidocaine is used to alleviate procedural pain but paradoxically increases pain during injection. Pain perception can be modulated by non-noxious stimuli such as temperature or touch according to the gate control theory of pain. We postulated that lidocaine dripped onto the skin prior to injection would cool or add the sensation of touch at the skin surface to reduce pain perception from the procedure.
A randomized clinical trial of patients referred to the procedure service from February 2011 through March 2015 was conducted. All patients received 1% subcutaneous lidocaine injection. Patients randomized to the intervention group had approximately 1 to 2 ml of lidocaine squirted onto the skin surface prior to subcutaneous lidocaine injection. Patients were blinded to the details of the intervention and were surveyed by a blinded investigator to document the primary outcome (severity of pain from the procedure) using a visual analog scale.
A total of 481 patients provided consent and were randomized to treatment. There was a significant improvement in the primary outcome of procedural pain (control, 16.6 ± 24.8 mm vs 12.2 ± 19.4 mm; P = .03) with the intervention group as assessed by using the visual analog scale score. Pain scores were primarily improved for peripherally inserted central catheters (control, 18.8 ± 25.6 mm vs 12.2 ± 18.2 mm; P = .02) upon subgroup analysis.
Bedside procedures are exceedingly common. Data regarding the severity of procedural pain and strategies to mitigate it are important for the informed consent process and patient satisfaction. Overall, pain reported from common bedside procedures is low, but pain can be further reduced with the addition of lidocaine onto the skin surface to modulate pain perception.
ClinicalTrials.gov; No.: NCT01330134; URL: www.clinicaltrials.gov.
利多卡因用于缓解程序疼痛,但矛盾的是,在注射过程中会增加疼痛。根据疼痛的门控理论,非伤害性刺激,如温度或触摸,可以调节疼痛感知。我们假设在注射前将利多卡因滴在皮肤上会冷却或增加皮肤表面的触感,从而减轻手术过程中的疼痛感知。
对 2011 年 2 月至 2015 年 3 月间转至该程序服务的患者进行了一项随机临床试验。所有患者均接受 1%的皮下利多卡因注射。随机分为干预组的患者在接受皮下利多卡因注射前,将约 1 至 2 毫升的利多卡因喷在皮肤表面。患者对干预措施的细节不知情,并由一名盲法调查员进行调查,使用视觉模拟评分法记录主要结局(手术过程中的疼痛严重程度)。
共有 481 名患者同意并随机分组接受治疗。使用视觉模拟评分法评估,干预组手术疼痛的主要结局(对照组,16.6 ± 24.8 毫米 vs 12.2 ± 19.4 毫米;P =.03)有显著改善。亚组分析显示,在经外周插入中心静脉导管(对照组,18.8 ± 25.6 毫米 vs 12.2 ± 18.2 毫米;P =.02)时疼痛评分改善更为明显。
床边操作非常常见。关于手术疼痛严重程度及其减轻策略的数据对于知情同意过程和患者满意度非常重要。总体而言,常见床边操作的疼痛程度较低,但通过在皮肤表面添加利多卡因来调节疼痛感知,可以进一步减轻疼痛。
ClinicalTrials.gov;编号:NCT01330134;网址:www.clinicaltrials.gov。